Nigel Ramsden

Nigel Ramsden is an experienced drug discoverer with a strong professional background in medicinal chemistry, drug discovery, and project management within the pharmaceutical and biotech industries. Previously serving as VP at Autophagix and CSO at CORRECTA4 BIO LIMITED, Nigel has delivered innovative projects from concept to clinical proof of concept. Currently, Nigel holds the position of Honorary Associate Professor at the University of Warwick and Vice President of Drug Discovery at Cerevance while continuing doctoral studies at the University of Oxford. Throughout their career, Nigel has co-invented key technologies and managed numerous drug discovery programs, driving advancements in therapeutic developments.